Medical Microbiology
Royal College of Physicians and Surgeons of Canada · 1.0 · 37 EPAs
Also available in French.
Every EPA in the published guide, shown as the form DebriefMD fills in, with its fields and answer options.
Transition to Discipline
TTD-1
Assessing patients and synthesizing information for presentation to a supervisor
Key features and assessment plan
- This EPA focuses on performing a clinical assessment, including history and physical exam, selecting investigations based on a differential diagnosis, and proposing a management plan. - This includes synthesizing the assessment to provide a comprehensive, concise, accurate, and well-organized case summary to a supervisor. - An important aspect of this EPA is working within one’s limits and recognizing situations where additional assistance is required.
Direct observation and case review by supervisor or Core or TTP resident Use form 1. Form collects information on: - Activity (select all that apply): history and physical examination; case summary and management plan - Observation: direct; case review Collect 3 observations of achievement - At least 1 history and physical examination - At least 1 case summary and management plan - At least 1 direct observation - At least 2 different assessors
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Activity
- history and physical examination
- case summary and management plan
Observation
- direct
- case review
Medical Expert
- ME 2.2 Gather a relevant clinical history
- ME 2.2 Perform a physical exam that informs the diagnosis
- ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor
- ME 2.2 Select appropriate investigations
- ME 2.4 Propose a management plan
Communicator
- COM 1.2 Optimize the physical environment for patient comfort, dignity, and privacy
- COM 2.3 Identify other sources of information (e.g., family, medical record) that may assist in the patient’s care
- COM 5.1 Document the clinical encounter using a structured approach
Professional
- P 1.1 Recognize one's own limits and seek assistance as needed
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-2
Following infection prevention and control precautions
Key features and assessment plan
- The focus of this EPA is assessing risk and applying protocols for airborne, contact, and droplet precautions appropriately, including following procedures for hand hygiene and donning and doffing PPE correctly. - This EPA may be observed in a simulation setting.
Direct observation by supervisor, IPAC practitioner, or Core or TTP resident Use form 1. Form collects information on: - Precautions: airborne; contact; droplet Collect 2 observations of achievement - At least 1 droplet or airborne precautions - At least 1 contact precautions
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Precautions
- airborne
- contact
- droplet
Medical Expert
- ME 2.2 Identify situations requiring the application of IPAC precautions
- ME 1.3 Apply knowledge of clinical conditions associated with contact, droplet, and airborne precautions
- ME 5.2 Follow procedures for IPAC, including handwashing and donning and doffing PPE
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-3
Participating in the pre-analytic assessment of specimens
Key features and assessment plan
- This EPA includes matching the requisition and container and/or specimen; applying knowledge of acceptance/rejection criteria, appropriate sample processing and selection of media type; and identifying samples that require urgent processing.
Direct observation and case discussion by supervisor or Core or TTP resident Use form 1. Form collects information on: - Sample type: blood; CSF; respiratory; urine; viral; other - Issue: test orders/requisitioning issue; sample issue - Setting: lab; simulation Collect 5 observations of achievement - At least 2 issues related to test orders/requisitioning - At least 3 issues related to sample - No more than 3 simulation cases
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Sample type
- blood
- CSF
- respiratory
- urine
- viral
- other
Issue
- test orders/requisitioning issue
- sample issue
Setting
- lab
- simulation
Medical Expert
- ME 3.1 Assess specimen quality, adequacy, and fit for the stated indication
- ME 3.1 Apply acceptance and rejection criteria
- ME 5.1 Resolve issues related to specimen misidentification
- ME 3.2 Identify specimens that require urgent processing
- ME 5.2 Apply safe practices in the laboratory to minimize occupational risk
Leader
- L 1.1 Apply knowledge of the principles of quality assurance pertinent to laboratory medicine
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTD-4
Performing Gram stains
Key features and assessment plan
- This EPA focuses on the technical skills and knowledge required to perform a Gram stain, including appropriate set up, use, and maintenance of a light microscope. - This includes recognition of microorganism shape, staining, and cell type. - At this stage, this does not require generating a microbiological “differential” based on Gram stain morphology.
Direct observation and case discussion by technologist, supervisor, or Core or TTP resident Use form 1. Form collects information on: - Organism classification: GPC chains; GPC clusters; GPB; GNB; GNCB; other Collect 3 observations of achievement - At least 2 different Gram stain morphologies
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Organism classification
- GPC chains
- GPC clusters
- GPB
- GNB
- GNCB
- other
Medical Expert
- ME 1.3 Apply knowledge of how a light microscope works
- ME 3.3 Perform basic microscope maintenance
- ME 1.3 Apply knowledge of the taxonomy and appearance of microorganisms and cells
- ME 3.3 Perform a Gram stain
- ME 3.3 Perform microscopy
- ME 3.4 Describe microorganism shape and staining and cell type
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Foundations
F-1
Advising on specimen collection for the diagnosis of common infectious diseases
Key features and assessment plan
- This EPA focuses on applying knowledge of infectious diseases and medical microbiology laboratory tests and procedures to provide advice and direction to others on obtaining specimens for bacteriology, mycobacteriology, virology, parasitology, mycology, serology, and molecular microbiology diagnostic testing. - This includes providing guidance about selection of the appropriate specimen (e.g., swab versus tissue) and container, collection in the correct manner, assessment of the quality of the specimen, and correct transport.
Direct observation by supervisor or Core or TTP resident Use form 1. Form collects information on: - Methodology: culture; molecular; serologic; microscopic - Sample type (write in): Collect 5 observations of achievement - At least 2 culture-based methods - At least 1 molecular-based method - At least 1 serologic method - At least 1 microscopic method - A variety of sample types
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Methodology
- culture
- molecular
- serologic
- microscopic
Medical Expert
- ME 2.2 Integrate and synthesize patient information to establish the clinical question
- ME 1.3 Apply knowledge of the procedures for specimen collection and identification
Communicator
- COM 2.3 Gather patient information from another health professional
Collaborator
- COL 1.3 Provide advice to clinical colleagues regarding specimen procurement and handling
- COL 1.3 Communicate effectively with other health professionals
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-2
Interpreting and reporting Gram stains of clinical specimens and culture isolates
Key features and assessment plan
- This EPA builds on the competencies of the Transition to Discipline stage and includes assessing the quality of the stain, identifying microorganism and cellular morphologies, differentiating normal flora and contaminants from organisms of significance, characterizing micro-organisms based on Gram stain and morphology, differentiating yeasts, budding yeasts, pseudohyphae, and hyphae, applying screening scores, and providing a report. - It also includes generating a differential diagnosis and/or clinical interpretation based on Gram stain morphology.
Direct observation or case discussion by technologist, supervisor, or Core or TTP resident Use form 1. Form collects information on: - Sample type: blood; sputum; sterile fluid; tissue; vaginal; wound; other - Organism classification: GPC chains; GPC clusters; GNB; GNCB; GPB; other Collect 5 observations of achievement - A variety of sample types - At least 4 different Gram stain morphologies
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Sample type
- blood
- sputum
- sterile fluid
- tissue
- vaginal
- wound
- other
Organism classification
- GPC chains
- GPC clusters
- GNB
- GNCB
- GPB
- other
Medical Expert
- ME 3.3 Perform a Gram stain
- ME 3.3 Perform microscopy
- ME 3.3 Assess the quality of the preparation and any impact on the diagnostic interpretation
- ME 3.3 Differentiate normal flora and contaminants from organisms of significance
- ME 3.3 Characterize microorganisms and cellular elements based on Gram stain and morphology
- ME 3.3 Apply screening scores and protocols as applicable
- ME 3.4 Formulate a differential diagnosis and clinical interpretation based on the morphologic assessment
- ME 3.4 Recognize when findings require urgent communication with the treating health care professional
- ME 3.4 Recognize when findings require notification to IPAC or public health authorities
Communicator
- COM 5.1 Provide a report of Gram stain findings
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-3
Identifying and reporting common organisms recovered on culture
Key features and assessment plan
- This EPA focuses on applying knowledge of the classification and basic characteristics of aerobic and anaerobic bacteria and yeasts. - This includes performing standard stains, selecting media and incubation conditions appropriate for the specimen type and/or anticipated pathogen(s), classifying the organism based on phenotypic characteristics, applying an approach to organism identification, determining the clinical significance and need for antimicrobial susceptibility testing of the isolate, and reporting the results accordingly (e.g., routine, critical, IPAC, diseases of public health significance). - The observation of this EPA is based on the review of specimens, which may include a series of unknowns, a series of mock specimens, or a few hours at the bench assessing regular specimens or unknowns.
Direct observation and/or case review of specimens by supervisor, dedicated teaching technologist, or Core or TTP resident Use form 1. Form collects information: - Observations based on: unknowns; mock specimens; bench work - Sample type (select all that apply): blood; sputum; sterile fluid; tissue; vaginal; wound; other - Organism classification (select all that apply): GNB; GPB; GPC; other bacteria of clinical significance; yeast; possible risk group 3 - Organism (write in): - Organisms that need interpretation for clinical significance: no; yes - Reporting (select all that apply): routine; critical results; IPAC; public health; other Collect 15 observations of achievement - A variety of sample types - At least 2 Gram-negative bacilli - At least 2 Gram-positive bacilli - At least 2 Gram-positive cocci - At least 2 other bacterial microorganisms of clinical significance (e.g., anaerobes, common fastidious – Haemophilus) - At least 2 yeasts - A variety of organisms - At least 2 organisms that need interpretation of clinical significance (e.g., antimicrobial susceptibility, pathogen vs normal flora, urine) - At least 2 organisms where the reporting includes critical results, IPAC, or public health considerations or critical notification
Suggested observations: 15
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.3 Apply knowledge of the principles of laboratory identification and speciation of microorganisms
- ME 3.3 Perform standard stains for organism identification for common aerobic and anaerobic bacteria and yeasts
- ME 3.3 Select culture media and incubation conditions
- ME 3.3 Select and use standard identification techniques
- ME 3.4 Interpret results of microorganism identification
- ME 3.3 Determine the clinical significance of an organism
- ME 3.3 Determine if there is a need for antimicrobial susceptibility testing
- ME 3.4 Recognize when findings require urgent communication with the treating health care professional
- ME 3.4 Recognize when findings require notification to IPAC or public health authorities
Communicator
- COM 5.1 Provide reports of microorganism identification
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-4
Performing, interpreting, and reporting antimicrobial susceptibility testing of common bacterial pathogens
Key features and assessment plan
- This EPA focuses on applying knowledge of common antimicrobial resistance patterns as well as laboratory methods and reference standards for detection of common intrinsic and acquired resistance mechanisms (e.g., ESBL, MRSA, VRE). - This includes selecting and applying appropriate standards and methodology for screening and confirmatory testing. - It also includes interpreting results and identifying results with significance for IPAC.
Direct observation or review of findings and report by supervisor, clinical microbiologist, dedicated teaching technologist, or Core or TTP resident Use form 1. Form collects information on: - Sample type (select all that apply): blood; sputum; sterile fluid; tissue; vaginal; wound; other - Age group: adult; pediatric; both - Organism classification: GNB; GPB; GPC; other bacteria of clinical significance - Methodology: automated methods; gradient diffusion; Kirby-Bauer; molecular methods; phenotypic methods; reference methods; other - Significance for IPAC: no; yes Collect 8 observations of achievement - A variety of samples - A mix of adult and pediatric samples - At least 2 specimens with Gram-positive cocci - At least 2 specimens with Gram-negative bacilli - At least 2 specimens with at least one other bacteria of clinical significance - A variety of methods - At least 2 specimens with an organism of significance for infection prevention and control (e.g., MRSA, VRE, CPE)
Suggested observations: 8
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Sample type
- blood
- sputum
- sterile fluid
- tissue
- vaginal
- wound
- other
Age group
- adult
- pediatric
- both
Organism classification
- GNB
- GPB
- GPC
- other bacteria of clinical significance
Methodology
- automated methods
- gradient diffusion
- Kirby-Bauer
- molecular methods
- phenotypic methods
- reference methods
- other
Significance for IPAC
- no
- yes
Medical Expert
- ME 3.3 Select appropriate reference methodology
- ME 3.3 Perform antimicrobial susceptibility testing
- ME 3.3 Select and use appropriate confirmatory testing as needed
- ME 1.3 Apply knowledge of common intrinsic and acquired resistance patterns
- ME 3.4 Interpret results of antimicrobial susceptibility testing
- ME 3.4 Recognize when findings require notification to IPAC or public health authorities
Communicator
- COM 5.1 Provide reports that follow a standardized format and approved guidelines and/or policies
Leader
- L 2.2 Apply the principles of antimicrobial stewardship
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-5
Recognizing the acuity of a patient’s illness, and initiating stabilization and management
Key features and assessment plan
- This EPA focuses on recognizing that a patient is or is likely to become critically ill and responding appropriately. - This includes prioritizing actions, implementing the primary priorities of resuscitation (airway, breathing, and circulation), and providing targeted treatment. - An important aspect of this EPA is the timely and appropriate recognition of the need for assistance and/or definitive management.
Direct observation or case review by supervisor or Core or TTP resident Use form 1. Form collects information on: - Age group: adult; pediatric - Clinical presentation (write in): Collect 4 observations of achievement - At least 1 in pediatric age group - At least 1 in adult age group - At least 4 different clinical presentations - At least 1 infectious clinical presentation
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Age group
- adult
- pediatric
Medical Expert
- ME 2.1 Determine the acuity of the issue and the priorities for patient care
- ME 2.2 Provide assessment and initial stabilization of ABCs
- ME 2.2 Perform a history and physical exam relevant to the patient presentation, in a time-effective manner
- ME 2.2 Select and/or interpret investigations
- ME 2.4 Develop and implement a plan for initial management
- ME 2.4 Determine the appropriate disposition and/or setting for ongoing care
Collaborator
- COL 1.3 Work effectively with the other health care professionals involved in the patient’s care
Professional
- P 1.1 Work within personal limits, seeking assistance as needed
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-6
Assessing and providing initial management for patients with acute presentations of common illnesses
Key features and assessment plan
- This EPA includes performing a history and physical examination for a patient with a new presentation or an exacerbation of a pre-existing illness. - It also includes developing a differential diagnosis and initial management plan, and presenting the case to a supervisor. - This includes both adult and pediatric patients, and a broad range of medical and surgical conditions. - This EPA does not include assessing and managing patients who are critically ill or have complex multisystem problems.
Direct observation or case discussion by supervisor or Core or TTP resident Use form 1. Form collects information on: - Age group: adult; pediatric - Category: infectious; non-infectious - Clinical condition (write in): Collect 4 observations of achievement - At least 1 in pediatric age group - At least 1 in adult age group - At least 1 infectious - At least 2 non-infectious
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Age group
- adult
- pediatric
Category
- infectious
- non-infectious
Medical Expert
- ME 2.2 Gather a relevant clinical history
- ME 2.2 Perform a physical exam relevant to the presentation
- ME 2.2 Select and/or interpret investigations
- ME 2.2 Develop a differential diagnosis
- ME 2.4 Develop a management plan
- ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor
Communicator
- COM 2.1 Use patient-centred interviewing skills
- COM 2.3 Seek and synthesize relevant information from other sources (e.g., family, medical record)
Collaborator
- COL 1.2 Work effectively as a member of the clinical team
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-7
Providing ongoing care for patients with common conditions and advancing their care plans
Key features and assessment plan
- This EPA focuses on the ongoing care of patients with common, non-complex conditions. - It includes ongoing reassessment of clinical status and management of the evolving clinical course, including further investigations, response to treatment, and possible complications. - The observation of this EPA includes pediatric and adult patients, and a range of clinical conditions.
Case discussion and review of progress notes by supervisor Use form 1. Form collects information on: - Age group: adult; pediatric - Category: infectious; non-infectious - Clinical condition (write in): Collect 4 observations of achievement - At least 1 in pediatric age group - At least 1 in adult age group - At least 1 infectious - At least 4 different clinical conditions
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Age group
- adult
- pediatric
Category
- infectious
- non-infectious
Medical Expert
- ME 2.2 Gather clinical information to assess health status and symptoms
- ME 2.2 Select and/or interpret investigations
- ME 2.2 Assess response to therapy, complications, and evolution of the clinical course
- ME 2.4 Adapt the management plan to the clinical course
- ME 1.6 Seek assistance as needed
Communicator
- COM 5.1 Document the clinical encounter to convey the clinical assessment and the rationale for decisions and/or recommendations
Collaborator
- COL 1.3 Integrate the patient’s perspective and context into the care plan
Health Advocate
- HA 1.2 Work with the patient and/or family to increase their understanding of their illness and health care needs
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-8
Assessing immunocompetent patients and initiating management for common infections
Key features and assessment plan
- This EPA includes performing a history and physical exam for patients with a confirmed or suspected infectious disease and developing a plan for initial management, including selecting investigations, recommending appropriate PPE and isolation based on the clinical syndrome, and selecting initial treatment. - It may include working with the medical microbiology laboratory team in the investigation and management of the case and diagnostic stewardship of laboratory resources.
Case review by supervisor with confirmation of physical examination findings as relevant Use form 1. Form collects information on: - Type of observation: direct; review of case - Age group: adult; pediatric - Setting: ICU; inpatient-medical; inpatient-surgical; outpatient; emergency department - System: cardiovascular; CNS; genital; GI; ophthalmic; osteoarticular; respiratory; skin and soft tissue; urinary; other (write in) Collect 5 observations of achievement - At least 2 with confirmation of physical exam findings - At least 1 in adult age group - At least 1 in pediatric age group - At least 1 in ICU setting - At least 1 in medical inpatient setting - At least 1 in surgical inpatient setting - A variety of systems
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Type of observation
- direct
- review of case
Age group
- adult
- pediatric
Setting
- ICU
- inpatient-medical
- inpatient-surgical
- outpatient
- emergency department
System
- cardiovascular
- CNS
- genital
- GI
- ophthalmic
- osteoarticular
- respiratory
- skin and soft tissue
- urinary
- other (write in)
Medical Expert
- ME 2.2 Apply infection control practices as appropriate to the clinical syndrome
- ME 2.2 Gather a clinical history, including the patient’s risk factors for infectious disease
- ME 2.2 Perform a physical exam relevant to the presentation
- ME 2.2 Select and/or interpret investigations
- ME 2.2 Develop a differential diagnosis
- ME 1.3 Apply knowledge of the principles of antimicrobial stewardship
- ME 2.4 Develop and implement a plan for initial management
- ME 2.2 Synthesize and organize clinical information for clear and succinct presentation to a supervisor
Communicator
- COM 2.3 Seek and synthesize relevant information from other sources (e.g., family, medical record)
Collaborator
- COL 1.2 Work effectively with the medical microbiology laboratory
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-9
Providing ongoing care for immunocompetent patients with a common infection
Key features and assessment plan
- This EPA focuses on the care that occurs over the course of a disease process. - This includes clinical reassessment, further investigation, and/or modification of treatment, including de-escalation, duration, iv to po modification, and adjustments based on therapeutic drug monitoring as appropriate, and making decisions about discharge and/or follow-up. - It may include working effectively with a consulting service and facilitating access to treatments and resources (e.g., outpatient antibiotic therapy).
Case review by supervisor Use form 1. Form collects information on: - Setting: ICU; inpatient-medical; inpatient-surgical; outpatient; emergency department - Issue: modify therapy based on incoming data and clinical response; management of complication or toxicity of therapy; sign-off of care with follow up as appropriate Collect 5 observations of achievement - At least 1 inpatient (ICU, medical, or surgical) - A variety of issues - At least 2 different observers
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Setting
- ICU
- inpatient-medical
- inpatient-surgical
- outpatient
- emergency department
Issue
- modify therapy based on incoming data and clinical response
- management of complication or toxicity of therapy
- sign-off of care with follow up as appropriate
Medical Expert
- ME 2.2 Gather clinical information to assess health status and symptoms
- ME 2.2 Assess response to therapy, complications, and evolution of the clinical course
- ME 2.2 Select and/or interpret investigations
- ME 2.4 Adapt the management plan based on response to therapy, adverse effects, and/or results of therapeutic drug monitoring
- ME 4.1 Provide recommendations for discharge and/or follow-up
Communicator
- COM 5.1 Document the clinical encounter to convey the clinical assessment and the rationale for decisions and/or recommendations
Collaborator
- COL 1.3 Integrate the patient’s perspective and context into the care plan
- COL 1.2 Work effectively with the consulting service and other health professionals
Health Advocate
- HA 1.2 Work with the patient and/or family to increase their understanding of their illness and health care needs
- HA 1.1 Facilitate access to needed health services and resources, e.g., outpatient antimicrobial therapy
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-10
Communicating clinical findings and management plans to patients and families
Key features and assessment plan
- This EPA focuses on the application of communication skills and strategies to convey information clearly and compassionately and engage the patient and family in shared decision-making.
Direct observation by supervisor Use form 1. Form collects information on: - Situation: diagnosis and treatment plan; discharge planning; counselling about adverse effects; other (write in) Collect 3 observations of achievement - At least 2 different situations
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Situation
- diagnosis and treatment plan
- discharge planning
- counselling about adverse effects
- other (write in)
Communicator
- COM 3.1 Provide accurate information about the medical condition and plans for investigation and/or management
- COM 3.1 Use plain language and avoid medical jargon
- COM 3.1 Use strategies to verify and validate the patient’s and/or family’s understanding
- COM 4.3 Answer questions from the patient and/or family
- COM 4.3 Use communication skills and strategies that help the patient and/or family make informed decisions
- COM 4.1 Communicate in a manner that is respectful, non-judgmental, and culturally aware
Health Advocate
- HA 1.3 Incorporate disease prevention, health promotion, and health surveillance activities into interactions with patients
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-11
Providing handover
Key features and assessment plan
- This EPA includes communicating patient or case information between health care professionals at times of transitions in care, prioritizing key clinical features, and providing guidance regarding anticipated changes in patient status or incoming patients, results, and other work. - It includes oral handover and/or written documentation when going off duty (end of day, end of call) and at the end of a rotation.
Direct observation or review of documentation with supervisor or Core or TTP resident Use form 1. Form collects information on: - Case mix: oral handover; written handover Collect 2 observations of achievement - At least 1 oral handover - At least 1 written handover
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Case mix
- oral handover
- written handover
Medical Expert
- ME 5.2 Use structured communication tools and strategies to enhance patient safety
Collaborator
- COL 3.2 Summarize and prioritize patient issues providing rationale for key decisions
- COL 3.2 Provide anticipatory guidance for ongoing management, such as results of outstanding investigations and/or anticipated events/outcomes
- COL 3.2 Clarify issues with the receiving physician(s), as needed
- COL 1.3 Integrate the patient’s perspective and context into the care plan
Professional
- P 1.1 Complete assigned responsibilities in a timely manner
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
F-12
Working effectively as a member of the interprofessional team
Key features and assessment plan
- This EPA focuses on the role of the physician as a member of the interprofessional team. - This includes contributing to the work of the team, understanding, and respecting the roles of other team members, and demonstrating appropriate professional behaviours. - This EPA will be observed in the laboratory as well as in clinical care settings.
Direct observation by supervisor with input from team members Use form 1. Form collects information on: - Setting: clinical; laboratory Collect 2 observations of achievement - At least 1 clinical setting - At least 1 laboratory setting - At least 2 different assessors
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Setting
- clinical
- laboratory
Collaborator
- COL 1.2 Demonstrate an understanding of the scope and expertise of other health care professionals
- COL 1.3 Communicate effectively with other health care professionals
- COL 1.1 Respond appropriately to input from other health care professionals
Professional
- P 1.1 Demonstrate punctuality
- P 1.1 Complete assigned responsibilities in a timely manner
- P 1.1 Behave in a professional manner
- P 1.1 Respond punctually to requests from patients or other health care professionals
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Core
C-1
Providing advice to physicians and other health care professionals about medical microbiology tests and results
Key features and assessment plan
- This EPA builds on the skills of the Foundations stage. - It focuses on gathering information about the request or issue to develop an understanding of the clinical question and make recommendations about selection of a test and/or about interpretation of results and patient management. - This includes aspects of resource stewardship related to laboratory utilization as well as antimicrobial selection, and effective communication and collaboration with clinical colleagues.
Direct observation and case review by microbiologist or TTP resident Use form 1: Form collects information on: - Category: bacteria; fungus; mycobacteria; parasite; virus; other - Issue: critical results; immunocompromised host; laboratory resource utilization; serology; other - Age group: adult; pediatric Collect at least 6 observations of achievement - At least 1 of each category - At least 1 immunocompromised host - At least 1 serology - At least 1 related to laboratory resource utilization - A mixture of adult and pediatric cases
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- bacteria
- fungus
- mycobacteria
- parasite
- virus
- other
Issue
- critical results
- immunocompromised host
- laboratory resource utilization
- serology
- other
Age group
- adult
- pediatric
Medical Expert
- ME 2.2 Integrate and synthesize patient information to establish the clinical question
- ME 2.4 Develop a plan for investigation and/or management
- ME 1.3 Apply knowledge of the principles of antimicrobial stewardship
Communicator
- COM 2.3 Gather patient information from another health professional
Collaborator
- COL 1.1 Establish positive relationships with other members of the health care team
- COL 1.3 Provide advice regarding procurement and handling of specimens, interpretation of laboratory findings, and/or appropriate use of antimicrobial therapy
- COL 1.3 Communicate effectively with other health professionals
Leader
- L 2.2 Apply evidence-based best practices to microbiology utilization
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-2
Identifying and reporting organisms
Key features and assessment plan
- This EPA includes performing standard identification procedures, which includes using phenotypic and genotypic methods to identify an organism, interpret its significance, determine the clinical significance and need for antimicrobial susceptibility testing of the isolate, and produce an accurate and timely report. - At this stage, this EPA applies to all clinically relevant pathogens including bacteria, mycobacteria, fungi, viruses, and parasites.
Direct observation and/or case review by supervisor, dedicated teaching technologist, senior technologist, microbiologist or TTP resident Use form 1. Form collects information on: - Category: bacteria; fungus; mycobacteria; parasite; virus - Organism (write in): - Methodology: direct antigen detection test; MALDI-TOF; microscopy; molecular microbiology; phenotypic; serology; viral culture Collect at least 25 observations of achievement - At least 5 bacteria - At least 5 fungi - At least 3 mycobacteria - At least 3 parasites - At least 5 viral specimens - A variety of organisms - At least 5 interpretations of molecular microbiology tests
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- bacteria
- fungus
- mycobacteria
- parasite
- virus
Medical Expert
- ME 1.3 Apply knowledge of the principles of laboratory identification and speciation of microorganisms
- ME 3.3 Select and/or perform standard stains for organism identification
- ME 3.3 Select culture media and incubation conditions
- ME 3.3 Select and use standard identification techniques
- ME 3.3 Select ancillary techniques in a resource-effective manner
- ME 3.3 Determine if a specimen, isolate, or microorganism requires referral to a reference laboratory
- ME 3.3 Determine the clinical significance of an organism
- ME 3.3 Determine if there is a need for antimicrobial susceptibility testing
- ME 3.4 Interpret results of microorganism identification
- ME 3.4 Recognize when findings require notification to IPAC or public health authorities
- ME 5.2 Apply biosafety and biosecurity measures in the laboratory
Communicator
- COM 5.1 Provide reports of microorganism identification
- COM 5.1 Document actions taken to communicate significant or unexpected findings
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-3
Directing, interpreting, and reporting antimicrobial susceptibility testing
Key features and assessment plan
- Building on the skills of the Foundations stage, this EPA focuses on susceptibility testing of bacterial microorganisms where there are discordant results, unusual or unexpected results, or when the organism is unusual, and may also include susceptibility testing for fungal organisms, viruses, and mycobacteria. - This includes directing the selection of antimicrobials to test, selecting phenotypic and genotypic testing as relevant, interpreting results, and identifying results with significance for IPAC. - It may include deciding to refer the sample to a reference laboratory and interpreting the results. - This EPA does not require the resident to perform the testing.
Direct observation or case discussion with supervisor, clinical microbiologist, or TTP resident Use form 1. Form collects information on: - Category: bacteria; fungus; mycobacteria; virus; other - Organism (write in): - Issue (select all that apply): interpretation; no reference criteria; need for repeat or confirmatory testing; multidrug resistance requiring additional testing; site-specific susceptibility; other (please specify) Collect at least 10 observations of achievement - At least 5 different bacterial organisms - At least 3 different fungal organisms - At least 2 mycobacterial organisms - At least 1 without reference criteria - At least 1 with that needs repeat or confirmatory testing - At least 1 with multidrug resistance requiring additional AST - At least 1 with site-specific susceptibility
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Category
- bacteria
- fungus
- mycobacteria
- virus
- other
Medical Expert
- ME 1.3 Apply knowledge of antimicrobial resistance patterns
- ME 3.3 Direct the selection of antimicrobials for testing
- ME 3.3 Select phenotypic and genotypic testing in a resource-effective manner
- ME 3.3 Determine action plan on discordant, unusual, or unexpected results
- ME 3.3 Determine if a specimen, isolate, or microorganism requires referral to a reference laboratory
- ME 3.4 Interpret results of antimicrobial susceptibility testing
- ME 3.4 Recognize when findings require notification to IPAC or public health authorities
Communicator
- COM 5.1 Provide reports that follow a standardized format and approved guidelines and/or policies
Leader
- L 2.2 Apply the principles of antimicrobial stewardship
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-4
Leading rounds in the laboratory
Key features and assessment plan
- This EPA focuses on providing clinical leadership in the day-to-day activities of the medical microbiology laboratory. - This includes resolving technical issues related to the identification of organisms and delegating tasks appropriately to team members. - It also includes addressing technologists’ questions about difficult-to-identify or unusual organisms, determining clinical significance of isolated organisms, and communicating results of laboratory investigations with stakeholders as appropriate. - The observation of this EPA is based on a week of the resident’s performance addressing issues that arise in rounds.
Direct observation and case review with supervisor or TTP resident Use form 1. Collect 3 observations of achievement - At least 2 different assessors
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 3.1 Address pre-analytical, analytical, and post-analytical issues
- ME 3.3 Select ancillary techniques in a resource-effective manner
- ME 3.3 Determine if a specimen, isolate, or microorganism requires referral to a reference laboratory
- ME 3.4 Interpret results of microorganism identification
- ME 3.4 Interpret results of antimicrobial susceptibility testing
- ME 5.2 Apply and adhere to quality management processes throughout the pre- analytic, analytic, and post-analytic phases
Collaborator
- COL 1.2 Provide guidance and support to laboratory staff to assess and resolve diagnostic challenges
- COL 1.2 Work effectively with laboratory staff
- COL 2.1 Delegate tasks and responsibilities in a respectful manner
- COL 1.3 Convey results to the treating health care professional, IPAC, or public health authorities as appropriate to the nature of the organism and urgency of the scenario
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-5
Recognizing and responding to biosafety risks in the laboratory
Key features and assessment plan
- This EPA focuses on the medical microbiologist’s role as a leader in ensuring laboratory biosafety procedures are followed and recognizing situations where there is a possible risk for laboratory workers. - This EPA includes identifying “red flags” related to risk group 3 and 4 pathogens (bacterial, viral, and fungal), applying biosafety principles (such as appropriate containment level, biosafety cabinet, PPE), ensuring appropriate storage and disposal of infectious agents, etc.
Direct observation and/or case review by supervisor Use form 1. Collect 2 observations of achievement
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 3.3 Identify “red flags” for biosafety
- ME 5.2 Apply biosafety and biosecurity measures in the laboratory
- ME 3.3 Determine if a specimen, isolate, or microorganism requires referral to a reference laboratory
Collaborator
- COL 1.2 Work effectively with laboratory staff
- COL 1.2 Provide guidance and support to laboratory staff to assess and resolve diagnostic challenges
Professional
- P 3.1 Adhere to regulations governing the transport, storage, and disposal of infectious agents
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-6
Managing a laboratory error or non-conforming event (NCE)
Key features and assessment plan
- This EPA includes identifying, responding to, disclosing, and documenting a laboratory error or NCE, as well as analyzing the event and potential improvements in medical microbiology practice or service delivery. - This EPA may be observed in simulation. - The achievement of this EPA must include at least one observation of an NCE requiring a detailed assessment.
Direct observation and review of documentation with supervisor (microbiologist), lab manager, senior laboratory tech, or TTP resident Use form 1. Form collects information on: - NCE type: pre-analytic; analytic; post-analytic - Detailed assessment: no; yes Collect 4 observations of achievement - At least 1 pre-analytic NCE - At least 1 analytic NCE - At least 1 post-analytic NCE - At least 1 requiring detailed assessment
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
NCE type
- pre-analytic
- analytic
- post-analytic
Detailed assessment
- no
- yes
Medical Expert
- ME 5.1 Recognize an event as a laboratory error or non-conforming event
- ME 5.1 Prioritize the initial response to mitigate the impact on patient safety
- ME 5.1 Identify what measures should be taken after an incident to contribute to process improvement
- ME 5.1 Report laboratory errors and non-conforming events as per institutional processes
Communicator
- COM 3.2 Identify circumstances where patient notification is required
Leader
- L 1.1 Recommend preventive, remedial, and/or corrective actions
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-7
Verifying and/or validating new tests
Key features and assessment plan
- This EPA focuses on the medical microbiologist’s role in assessing and adopting new tests in the laboratory. - This includes participating in the design of a test verification/validation protocol, performing aspects or components of the verification/validation, coordinating the study with lab personnel, and analyzing results to decide on acceptability criteria. - This EPA may be observed in simulation. - This EPA may be observed with either verification or validation of a new diagnostic test (qualitative or quantitative) for either screening, diagnosis, or monitoring.
Review of documentation or presentation with supervisor (microbiologist) Use form 1 Collect 1 observation of achievement
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Collaborator
- COL 1.3 Work effectively with laboratory personnel and relevant stakeholders
Leader
- L 3.1 Participate in the design of a test verification/validation protocol
- L 3.1 Coordinate the performance of test verification/validation with laboratory personnel
- L 3.1 Analyze results and determine acceptability criteria
- L 3.1 Recommend for or against the adoption of a new test
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-8
Developing or revising standard operating procedures and test algorithms
Key features and assessment plan
- This EPA includes applying evidence-based best practices, reviewing pertinent laboratory data, and incorporating biosafety considerations to create or formally review standard operating procedures and testing algorithms. - This includes identification of and communication with appropriate stakeholders.
Review of SOP report with supervisor (microbiologist), which may include input from laboratory technologists Use form 1. Form collects information on: - SOP: review of existing SOP; creation of new SOP - Stage: pre-analytic; analytic; post-analytic Collect 2 observations of achievement - At least 1 review of an existing SOP
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
SOP
- review of existing SOP
- creation of new SOP
Stage
- pre-analytic
- analytic
- post-analytic
Collaborator
- COL 1.3 Work effectively with laboratory personnel and relevant stakeholders
Leader
- L 1.4 Review pertinent laboratory data to assess current practice
- L 2.2 Determine cost differences between best practice and current practice
- L 3.1 Determine the appropriate standard operating procedure or test algorithm
- L 3.1 Document recommendations using the appropriate format
- L 3.1 Identify the impact of a change in test methodology or availability and the stakeholders who may be affected by the change
- L 3.1 Develop the communication strategy for a change in laboratory practice
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-9
Providing quality assurance and improvement of medical microbiology practice or services
Key features and assessment plan
- This EPA focuses on the design and completion of a quality improvement or quality assurance project (e.g., audit), including a review and analysis of a set of events, data, or outcomes to ascertain the quality of medical microbiology practice or services. - This includes designing and performing the audit and analyzing the reasons for any gap in desired outcomes and may include providing suggestions for potential improvement. - The observation of this EPA requires that the resident complete the analysis, but it is not necessary for the resident to implement or participate in the implementation of any changes. - This EPA will be observed via presentation of findings (e.g., at rounds, a conference or to a committee) or via submission of a report.
Review of submission by supervisor Use form 1 Collect 1 observation of achievement
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Collaborator
- COL 1.3 Work effectively with laboratory personnel and relevant stakeholders
Leader
- L 1.4 Apply knowledge of the metrics and measurement systems used to track quality management, utilization, and safety activities
- L 1.1 Review and analyze data to ascertain the quality of medical microbiology services
- L 1.1 Identify variation/gaps between actual and targeted performance
- L 1.1 Perform an analysis of the reason(s) for the gap in desired outcomes
- L 1.1 Apply knowledge of process improvement methodologies
- L 1.1 Recommend preventive, remedial, and/or corrective actions
Scholar
- S 3.4 Integrate best evidence and clinical expertise
Professional
- P 1.2 Demonstrate a commitment to continuous quality improvement
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-10
Performing antimicrobial stewardship review and providing feedback
Key features and assessment plan
- This EPA focuses on optimizing the selection of antimicrobial therapy. - This includes conducting a focused clinical consult to determine appropriateness of an antimicrobial regimen, identifying opportunities to modify therapy, and providing recommendations for the most appropriate targeted treatment regimen, which may include dosing, duration, possible oral de-escalation, and/or therapeutic drug monitoring as necessary.
Direct observation and review of documentation with supervisor (Med Micro or ID), pharmacist, or TTP resident Use form 1. Form collects information on: - Class of antibiotic (write in): - Setting: ICU; ward; emergency department; community Collect 4 observation of achievement - At least 2 different classes of antibiotics - At least 2 different settings
Suggested observations: 4
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 2.2 Gather information about the clinical presentation
- ME 2.2 Correlate the findings of investigation with the clinical presentation
- ME 2.2 Determine the appropriateness of the antimicrobial regimen
- ME 2.4 Provide recommendations for antimicrobial selection, including dose, route of administration, and duration of therapy
- ME 2.4 Provide recommendations for de-escalation and monitoring of antimicrobial treatment
Collaborator
- COL 1.3 Communicate effectively with other health care professionals
Leader
- L 2.2 Identify opportunities for antimicrobial stewardship
Scholar
- S 3.4 Integrate best evidence and clinical expertise
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-11
Participating in outbreak management
Key features and assessment plan
- This EPA focuses on the response to an outbreak of an infectious agent from the perspective of infection prevention and control, the laboratory, and/or public health. - This includes outbreak investigation, management, and communication. - This EPA may be observed with outbreaks in a health care facility or community setting, or in simulation.
Direct observation and case review by supervisor, public health physician and/or nurse, or TTP resident, which may include input from members of the IPAC team (physician, nurse and/or other) or unit manager as appropriate Use form 1. Form collects information on: - Setting: hospital; community; simulation - Resident role (select all that apply): declare outbreak; lab assessment (pathogen identification and typing); epidemiological assessment Collect at least 1 observation of achievement - At least 1 observation of each role
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Setting
- hospital
- community
- simulation
Resident role
- declare outbreak
- lab assessment (pathogen identification and typing)
- epidemiological assessment
Medical Expert
- ME 2.2 Gather information about the situation and determine if an outbreak is occurring
- ME 2.2 Characterize the outbreak, both quantitatively and qualitatively
- ME 2.2 Assess causality and degree of risk associated with exposure
- ME 2.4 Develop a plan for control and prevention measures
- ME 2.2 Advise on and select appropriate lab methodologies to support outbreak investigation
- ME 2.4 Develop a plan for surveillance and monitoring
Collaborator
- COL 1.3 Convey information to other health care professionals in a manner that enhances patient care and the work of the outbreak team/committee
- COL 1.2 Work effectively with other members of the IPAC and outbreak team and with public health
Professional
- P 3.1 Adhere to requirements for mandatory reporting
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-12
Providing infection control consultations
Key features and assessment plan
- This EPA focuses on providing consultation to infection control practitioners or other health care professionals regarding an infection control question. - This includes gathering and/or reviewing clinical information about the request and synthesizing clinical data with results of investigations to develop an understanding of the clinical question and make recommendations about infection control procedures, surveillance, and/or prophylaxis, as relevant.
Consult discussion with supervisor, public health physician and/or nurse, or TTP resident Use form 1. Form collects information on - Exposure: viral - respiratory; viral – GI; mycobacteria; other - Organism (write in): - Post-exposure prophylaxis required: no; yes Collect 5 observations of achievement - At least 4 different exposures - At least 1 requiring post-exposure prophylaxis
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Exposure
- viral - respiratory
- viral – GI
- mycobacteria
- other
Medical Expert
- ME 2.2 Gather and/or review clinical information related to the request for IPAC consultation
- ME 2.2 Synthesize clinical information and results of investigations to develop an understanding of the clinical question
- ME 2.4 Provide recommendations for pharmacologic and non-pharmacologic preventive interventions
- ME 2.4 Provide recommendations for investigations or screening tests
- ME 2.4 Provide recommendations for surveillance procedures
Collaborator
- COL 1.3 Communicate effectively with physicians and other health care professionals, and other stakeholders
- COL 1.3 Support clinical colleagues in the development and implementation of a management plan
Professional
- P 3.1 Adhere to requirements for mandatory reporting
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-13
Assessing inpatients with a complex and/or chronic infectious disease presentation and initiating management
Key features and assessment plan
- This EPA includes collecting and synthesizing clinical and epidemiologic information to formulate a differential diagnosis, select investigations, and develop a treatment plan. - This includes applying knowledge of infection control, pharmacology, and antimicrobial stewardship as they pertain to the case, and liaising with microbiology, public health, and other specialty services as appropriate. - Examples include patients who are immunocompromised (acquired or primary immunodeficiency), fever of unknown origin/non-infectious mimics, infectious complications of a substance use disorder, travel related illnesses, or other exposures/epidemiologic risk factors, and patients with a critical illness (e.g., ICU, PICU, NICU). - Complex presentations include those that have inadequate source control, are not responding to usual therapy, and/or require special access to treatment (e.g., ARO).
Case review by supervisor or TTP resident Use form 1. Form collects information on: - Age group: adult; pediatric - Setting: ICU; inpatient – medical; inpatient – surgical; emergency department - Immunocompromised: no; yes Collect 5 observations of achievement - At least 1 of each patient age group - At least 3 different settings - At least 2 immunocompromised patients
Suggested observations: 5
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Age group
- adult
- pediatric
Setting
- ICU
- inpatient – medical
- inpatient – surgical
- emergency department
Immunocompromised
- no
- yes
Medical Expert
- ME 1.4 Perform a clinical assessment that addresses all relevant issues
- ME 2.2 Select and/or interpret investigations
- ME 2.2 Formulate a differential and most likely diagnosis
- ME 2.2 Integrate information about the patient’s presentation, concurrent illnesses, and other factors that may impact the diagnosis or outcome
- ME 2.4 Develop a management plan
- ME 4.1 Develop a plan for follow-up
Collaborator
- COL 1.3 Work effectively with the other health care professionals involved in the patient’s care
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-14
Providing ongoing care for inpatients with a complex and/or chronic infectious disease
Key features and assessment plan
- This EPA includes reassessment of the patient to evaluate changes in their clinical condition, interpret results of new investigations, assess response to therapy, and identify any complications and side effects. - It also includes recognizing the need for change, escalation or de-escalation of therapy and formulating a plan for ongoing monitoring, follow-up, and completion of treatment as an inpatient or outpatient. - This may include liaising with the referring physician, and microbiology, public health and other specialty services as appropriate.
Case review by supervisor, TTP resident, ID pharmacist, or receiving physician Use form 1. Form collects information on - Issue: modify therapy based on incoming data and clinical response; management of complication or toxicity of therapy; sign-off or transfer of care with follow up as appropriate Collect 6 observations of achievement - At least 3 modifying therapy based on incoming data and clinical response - At least 1 managing complication or toxicity of therapy - At least 2 sign off or transfer of care with follow-up as appropriate - At least 2 different observers
Suggested observations: 6
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Issue
- modify therapy based on incoming data and clinical response
- management of complication or toxicity of therapy
- sign-off or transfer of care with follow up as appropriate
Medical Expert
- ME 1.4 Perform a clinical assessment that addresses all relevant issues
- ME 2.2 Interpret the results of investigations performed to monitor the condition and/or its treatment
- ME 2.2 Synthesize patient information to determine clinical status and response to treatment
- ME 2.4 Adapt the management plan based on response to therapy, adverse effects, and/or results of therapeutic drug monitoring
- ME 2.4 Provide recommendations for antimicrobial selection, including dose, route of administration, and duration of therapy
- ME 4.1 Provide recommendations for discharge and/or follow-up
Communicator
- COM 5.1 Document the clinical encounter to convey the clinical assessment and the rationale for decisions and/or recommendations
Collaborator
- COL 1.3 Integrate the patient’s perspective and context into the care plan
- COL 1.2 Work effectively with the consulting service and other health professionals
Leader
- L 2.1 Consider costs and resource availability when selecting treatment options
Health Advocate
- HA 1.1 Facilitate access to needed health services and resources, e.g., outpatient antimicrobial therapy
- HA 1.2 Work with the patient and/or family to increase their understanding of their illness and health care needs
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-15
Providing consultation and ongoing care in the outpatient setting
Key features and assessment plan
- This EPA focuses on providing care in the outpatient setting, including initial consultation and/or ongoing management. - This includes assessment of the patient’s condition and development of or reassessment of the treatment plan which may include surveillance for complications of the infection or its treatment, monitoring of therapy and response to therapy, and plans for follow-up. - It also includes addressing patient concerns and providing education, applying knowledge of resources in the outpatient setting, and helping patients access those resources when needed. - This EPA may be observed in the clinic as well as with OPAT.
Case review by supervisor Use form 1. Form collects information on - Type of visit: new consult; follow-up - System: cardiovascular; CNS; ENT; GI; intra-abdominal; ophthalmic; osteoarticular; respiratory; skin and soft tissue; STI; systemic/disseminated; urinary; other Collect 6 observations of achievement - A mixture of new consults and follow-up visits - A variety of systems
Suggested observations: 6
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Type of visit
- new consult
- follow-up
System
- cardiovascular
- CNS
- ENT
- GI
- intra-abdominal
- ophthalmic
- osteoarticular
- respiratory
- skin and soft tissue
- STI
- systemic/disseminated
- urinary
- other
Medical Expert
- ME 1.4 Perform a clinical assessment that addresses all relevant issues
- ME 2.2 Select and/or interpret investigations
- ME 2.2 Integrate information about the patient’s presentation, concurrent illnesses, and other factors that may impact the diagnosis or outcome
- ME 2.4 Develop a management plan
- ME 4.1 Develop a plan for follow-up
- ME 4.1 Determine the need and timing of referral to another health care professional
Communicator
- COM 5.1 Document the clinical encounter to convey the clinical assessment and the rationale for decisions and/or recommendations
Collaborator
- COL 1.3 Work effectively with the other health care professionals involved in the patient’s care
Leader
- L 2.1 Consider costs and resource availability when selecting treatment options
Health Advocate
- HA 1.1 Facilitate access to needed health services and resources, e.g., outpatient antimicrobial therapy
- HA 1.2 Work with the patient and/or family to increase their understanding of their illness and health care needs
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-16
Providing immunization and prophylaxis consultations
Key features and assessment plan
- This includes performing a clinical assessment and providing counselling, guidance, and preventive care. - Examples include pre-splenectomy, pre-surgical, pre-travel and vaccine recommendations, post-exposure prophylaxis, and harm reduction consultations.
Case review with supervisor Use form 1. Form collects information on - Presentation: immunocompromised (e.g., pre-immunosuppression, pre-transplant, splenectomy, other); pre-exposure prophylaxis/harm reduction; post-exposure prophylaxis; pre-surgical; vaccine-related counselling; infant of HIV+ mother; pre- travel counselling - Direct observation of counselling: no; yes Collect 3 observations of achievement - At least 3 different presentations - At least 1 direct observation of counselling - At least 2 different observers
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Presentation
- immunocompromised (e.g., pre-immunosuppression, pre-transplant, splenectomy, other)
- pre-exposure prophylaxis/harm reduction
- post-exposure prophylaxis
- pre-surgical
- vaccine-related counselling
- infant of HIV+ mother
- pre- travel counselling
Direct observation of counselling
- no
- yes
Medical Expert
- ME 1.4 Perform a clinical assessment that addresses all relevant issues
- ME 2.2 Assess individualized risk for acquisition of infectious disease
- ME 2.4 Provide recommendations for immunization, prophylaxis, and/or harm reduction
Communicator
- COM 1.3 Elicit the patient’s and/or family’s beliefs, concerns, and expectations for the clinical encounter
- COM 3.1 Provide information and explanations that are clear and accurate
- COM 4.3 Solicit and answer questions from the patient and/or family
- COM 4.1 Obtain informed consent for procedures or vaccines
- COM 1.1 Respect patient autonomy, privacy, and confidentiality
Health Advocate
- HA 1.2 Provide education resources and facilitate services for the patient and/or family
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-17
Documenting clinical encounters
Key features and assessment plan
- This EPA focuses on the application of written communication skills in a variety of formats: consultations; progress notes. - This includes a synthesis of the pertinent clinical findings, investigations, and management plan, as well as clear articulation of the rationale for the treatment plan and education around pertinent issues, including concepts of antimicrobial stewardship, microbiology, and pharmacology. - It may include linking the recommendations to evidence-based guidelines or other educational references for the referring physician. - The documents submitted for review must be the sole work of the resident.
Review of clinical documentation by supervisor Use form 1. Form collects information on: - Document: inpatient consultation; outpatient consultation; inpatient progress note; outpatient progress note; sign-off, discharge, or transfer note Collect 3 observations of achievement - At least 1 consultation note - At least 1 sign-off, discharge, or transfer note - At least 2 different assessors
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Document
- inpatient consultation
- outpatient consultation
- inpatient progress note
- outpatient progress note
- sign-off, discharge, or transfer note
Communicator
- COM 5.1 Organize information in appropriate sections
- COM 5.1 Document all relevant findings and investigations in an organized, concise, and legible manner
- COM 5.1 Convey clinical reasoning and the rationale for decisions
- COM 5.1 Provide a clear plan for ongoing management
- COM 5.1 Complete clinical documentation in a timely manner
Collaborator
- COL 1.2 Identify the roles of the referring physician and the medical microbiology consultant in the ongoing management plan
- COL 3.2 Provide anticipatory guidance for results of outstanding investigations and/or next steps for management
- COL 2.1 Convey information thoughtfully and respectfully
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
- S 1.3 Provide teaching points to improve quality of care
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
C-18
Providing formal teaching for a variety of audiences
Key features and assessment plan
- This EPA focuses on the skills of literature review and critical appraisal as well as presentation and teaching skills aimed at the needs of the audience. - The observation of this EPA is based on a formal presentation provided to any audience on a topic related to Medical Microbiology. - Examples include rounds, journal club, presentation to the public, presentation to a multidisciplinary audience, and medical student/resident teaching.
Direct observation by supervisor, which may include feedback from the audience Use form 1. Form collects information on: - Topic (write in): Collect 3 observations of achievement - A variety of topics
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Scholar
- S 2.4 Identify the learning needs and desired learning outcomes of others
- S 2.4 Develop learning objectives for a teaching activity
- S 3.3 Critically evaluate the integrity, reliability, and applicability of research, guidelines, and literature
- S 3.4 Integrate best evidence and clinical expertise
- S 2.4 Present the information in an organized manner to facilitate understanding
- S 2.4 Use audiovisual aids effectively
- S 2.4 Provide adequate time for questions and discussion
- S 2.4 Respond effectively to questions
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
Transition to Practice
TTP-1
Providing clinical leadership for medical microbiology laboratory services
Key features and assessment plan
- This EPA includes providing medical microbiology expertise to resolve pre-analytic, analytic, and post-analytic issues that arise in the daily work of the laboratory and respond to questions regarding test selection and utilization, specimen collection, and interpretation of results. - It may also include addressing operational issues (i.e., equipment breakdown) in order to provide ongoing quality of the delivery of laboratory services. - It also includes working effectively with the laboratory technologists and lab management. - The observation of this EPA is based on at least one week’s work.
Direct and indirect observation by supervisor Use form 1. Collect 3 observations of achievement - At least 2 different assessors
Suggested observations: 3
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.1 Demonstrate a commitment to high-quality health care services
- ME 5.2 Apply and adhere to quality management processes throughout the pre-analytic, analytic, and post-analytic phases
- ME 1.5 Carry out professional duties in the face of multiple competing demands
Collaborator
- COL 1.2 Provide guidance and support to laboratory staff to assess and resolve diagnostic challenges
- COL 1.2 Work effectively with peers, faculty members, laboratory staff, administrative personnel, and managers of technical staff
- COL 1.3 Provide guidance and support for questions arising from clinical colleagues, IPAC, public health, or other stakeholders
Leader
- L 3.1 Prioritize tasks in the laboratory to provide services in a timely manner
- L 3.1 Adapt or develop solutions to address issues in service delivery, such as equipment malfunction and reagent shortfalls
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- P 1.1 Work within personal limits, seeking assistance as needed
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTP-2
Managing an inpatient consultation service
Key features and assessment plan
- This EPA includes all aspects of leading a consultation service, including triaging referrals, delegating and organizing the work of junior members of the team, supervising junior learners, making decisions for patient care, arranging ongoing patient care, and working effectively with referring physicians. - The observation of this EPA is based on a period of at least one week.
Direct and indirect observation by supervisor Use form 1 Collect 2 observations of achievement - At least 2 different assessors
Suggested observations: 2
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Medical Expert
- ME 1.1 Demonstrate responsibility and accountability for patient care within the boundaries and expectations of the consultant role
- ME 2.1 Triage referrals on the basis of clinical acuity
- ME 2.4 Establish management plans that consider all relevant aspects of the patient’s care
Collaborator
- COL 1.3 Communicate effectively with the consulting service
- COL 2.2 Work effectively with other health care professionals when there are differences in opinion and/or recommendations
Leader
- L 4.1 Manage time and prioritize tasks
- L 4.1 Integrate supervisory and teaching responsibilities into the overall management of the clinical service
Scholar
- S 3.4 Integrate best evidence and clinical expertise into decision-making
Professional
- P 1.1 Behave in a professional manner 10 L4.2 Run the service efficiently, safely, and effectively
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.
TTP-3
Contributing expertise at interprofessional meetings
Key features and assessment plan
- This EPA focuses on the role of the medical microbiologist providing expertise to team discussions. - Examples include antibiotic stewardship committees, lab meetings, pharmacy and therapeutics committees, infection control meetings, residency program committee, and quality assurance/improvement meetings. - This may include preparing for the meeting, responding to questions related to medical microbiology expertise, working effectively with other health care professionals and/or administrators and demonstrating professional behaviour.
Direct observation by supervisor, which may include input from other participants Use form 1. Collect 1 observation of achievement
Suggested observations: 1
Entrustment (how much supervision did this activity need?)
- I had to do
- I had to talk them through
- I needed to prompt
- I needed to be there just in case
- I didn’t need to be there
Collaborator
- COL 1.3 Contribute medical microbiology expertise to the discussion
- COL 1.3 Communicate effectively with other health care professionals
- COL 1.3 Demonstrate respect for the opinions of other meeting participants
Leader
- L 3.1 Summarize and clarify key points, discussions, and action items
Scholar
- S 3.4 Integrate best evidence and clinical expertise
Professional
- P 1.2 Prepare for a meeting, reviewing its purpose, and any relevant background information
- P 1.1 Behave in a professional manner
Case description
Feedback provided
Next steps
Copyright © 2023 The Royal College of Physicians and Surgeons of Canada. Referenced and produced with permission.